Response to Letter to the Editor: Melanocortin-4 (MC4) Receptor Antagonists Will Be Better Used in the Future

2012 ◽  
Vol 122 (9) ◽  
pp. 548-548
Author(s):  
Haichen Chu ◽  
Jiangling Xia
Keyword(s):  
Receptor Antagonists ◽  
Letter To The Editor ◽  
The Future

The Pharmacology of Antiulcer Drugs

DICP ◽  
1989 ◽  
Vol 23 (10_suppl) ◽  
pp. S10-S16 ◽  
Author(s):  
Aryeh Hurwitz ◽  
Charles A. Carter
Keyword(s):  
Ulcer Formation ◽  
Receptor Antagonists ◽  
Rational Use ◽  
Causative Factors ◽  
Days Of Therapy ◽  
The Future ◽  
Antiulcer Drugs

The use of medications for the treatment of gastrointestinal ulcers has evolved to a great extent since the early days of therapy with diet and antacids. Today a number of different agents are available to treat the causative factors of ulcer formation. Currently, antacids, histamine2-receptor antagonists, and sucralfate are considered frontline therapies suitable for most patients. The future also looks promising for newer agents, such as omeprazole and prostaglandin analogs. The purpose of this article is to provide practitioners with an understanding of the pharmacology of these agents so that their rational use can be achieved more efficiently and effectively.

scholarly journals Response to Letter to the Editor on “Digital Orthopedics. A Glimpse Into the Future in the Midst of a Pandemic”

2020 ◽  
Vol 35 (10) ◽  
pp. 3056 ◽  
Author(s):  
Stefano A. Bini ◽  
Peter L. Schilling ◽  
Shaun P. Patel ◽  
Niraj V. Kalore ◽  
Michael P. Ast ◽  
...  
Keyword(s):  
Letter To The Editor ◽  
The Future

Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future

Drugs ◽  
2015 ◽  
Vol 75 (11) ◽  
pp. 1229-1253 ◽  
Author(s):  
Giuseppe De Luca ◽  
Stefano Savonitto ◽  
Arnoud W. J. van’t Hof ◽  
Harry Suryapranata
Keyword(s):  
Primary Angioplasty ◽  
Receptor Antagonists ◽  
The Future

COVID-19 y su asociación con los IECA y ARAII

2020 ◽  
Vol 63 (6) ◽  
pp. 54-57
Author(s):  
Alejandro Jahén García Delgado ◽  
Lorenzo García
Keyword(s):  
Angiotensin Ii ◽  
Angiotensin Converting Enzyme ◽  
Enzyme Inhibitors ◽  
Angiotensin Converting Enzyme Inhibitors ◽  
Converting Enzyme ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Receptor Antagonists ◽  
Converting Enzyme Inhibitors ◽  
Letter To The Editor

MD. Alejandro Jahén García Delgado's letter to the Editor, provides an interesting opinion on the article ""COVID-19 and its Association with Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists"" by authors Luis M. Montaño Ramírez and Edgar Flores-Soto, published in Rev Fac Med (UNAM), 2020:63(4).

Sign in / Sign up

Export Citation Format

Share Document